Centamin shares rise on gold prices, director dealing

Centamin shares surged Friday as gold prices improved and a director acquired a further stake in the Egypt-focused miner.

Centamin shares surged Friday as gold prices improved and a director acquired a further stake in the Egypt-focused miner.

The price of gold received a boost following the strong selling pressure seen earlier in the week. The yellow metal had been trading near steady levels just ahead of the release of surprisingly weak US payroll figures Friday afternoon.

June Comex gold last traded up $11.50 at $1,563.90 an ounce. Spot gold was last quoted up $9.60 at $1,563.75.

The market learned that Mark Bankes, Non Executive Director, on Friday bought 30,000 shares in Centamin at a price of 42.92p, bringing his total holding to 120,000.

Shares were also shooting up after hitting a nine-month low Thursday, which had seen the shares enter so-called 'oversold' territory.

The above also came on the heels of a downgrade yesterday from analysts at Canaccord Genuity, who lowered their rating from 'buy' to 'sell'.

"Although financial results released last week were relatively strong the key decision on the validity of the Sukari mining license is fairly distant," the broker said.

"The Egyptian judicial system continues to be affected by political instability and we now expect the final court ruling to take around 12 months to be released. This puts a lid on the upside and creates room for potential negative news flow and media speculation during 2013," Canaccord added.

Last week Centamin announced a 30% rise in full-year gold production which helped push pre-tax profit up to $198.6m from $194m previously.

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Aviva: a share for income investors to tuck away
Share tips

Aviva: a share for income investors to tuck away

Insurance giant Aviva is one of the highest yielding stocks in the FTSE 100 – and it’s cheap, too, making it a tempting target for income investors. R…
18 May 2022
Despite the crypto crash, bitcoin still has a bright future
Bitcoin & crypto

Despite the crypto crash, bitcoin still has a bright future

Cryptocurrencies have crashed hard, with bitcoin down by more than 50% from its peak. But, says Dominic Frisby, bitcoin still has a future – it is the…
19 May 2022